Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Health
Related: About this forumCancer drug prices are so high that doctors will test cutting doses
Source: Washington Post
Cancer drug prices are so high that doctors will test cutting doses
By Laurie McGinley June 8 at 3:01 PM
A group of prominent cancer doctors is planning a novel assault on high drug costs, using clinical trials to show that many oncology medications could be taken at lower doses or for shorter periods without hurting their effectiveness. As Exhibit A, they point to their pilot study involving a widely prescribed drug for advanced prostate cancer. Cutting the standard dose of Zytiga by three-quarters was as effective as taking the full amount as long as patients swallowed the medication with a low-fat breakfast rather than on an empty stomach, as directed by the label.
It's inefficient, even wasteful, to take this medicine while fasting, University of Chicago oncologist Russell Szmulewitz said in presenting the data at a conference earlier this year. Reducing the dosage of the $9,400-a-month medication as studied would sharply lower costs even for well-insured patients, he said. Another benefit would be fewer side effects; the patients who'd eaten breakfast with Zytiga, for example, had fewer stomach issues.
Szmulewitz and others now want to run full trials to see whether the doses of other oral oncology drugs can be ratcheted back because of the food effect, which can alter how a medication is absorbed. They also plan to explore whether the duration of some prescriptions can be shortened and whether some cheaper non-cancer drugs can be substituted for expensive cancer ones. They recently created a nonprofit organization, the Value in Cancer Care consortium, to organize their work.
The initiative is the latest response to rising concerns over financial toxicity, the economic devastation that can be wrought by the high cost of cancer care. With new oncology therapies routinely debuting at more than $100,000 a year, lots of people are worried about developing drugs that people can't get, said Leonard Saltz of Memorial Sloan Kettering Cancer Center in New York, who helped organize the new group. The effort is also an acknowledgment that, despite President Trump's grousing about high drug prices earlier this year, they're unlikely to change soon.
[font size=1]-snip-[/font]
By Laurie McGinley June 8 at 3:01 PM
A group of prominent cancer doctors is planning a novel assault on high drug costs, using clinical trials to show that many oncology medications could be taken at lower doses or for shorter periods without hurting their effectiveness. As Exhibit A, they point to their pilot study involving a widely prescribed drug for advanced prostate cancer. Cutting the standard dose of Zytiga by three-quarters was as effective as taking the full amount as long as patients swallowed the medication with a low-fat breakfast rather than on an empty stomach, as directed by the label.
It's inefficient, even wasteful, to take this medicine while fasting, University of Chicago oncologist Russell Szmulewitz said in presenting the data at a conference earlier this year. Reducing the dosage of the $9,400-a-month medication as studied would sharply lower costs even for well-insured patients, he said. Another benefit would be fewer side effects; the patients who'd eaten breakfast with Zytiga, for example, had fewer stomach issues.
Szmulewitz and others now want to run full trials to see whether the doses of other oral oncology drugs can be ratcheted back because of the food effect, which can alter how a medication is absorbed. They also plan to explore whether the duration of some prescriptions can be shortened and whether some cheaper non-cancer drugs can be substituted for expensive cancer ones. They recently created a nonprofit organization, the Value in Cancer Care consortium, to organize their work.
The initiative is the latest response to rising concerns over financial toxicity, the economic devastation that can be wrought by the high cost of cancer care. With new oncology therapies routinely debuting at more than $100,000 a year, lots of people are worried about developing drugs that people can't get, said Leonard Saltz of Memorial Sloan Kettering Cancer Center in New York, who helped organize the new group. The effort is also an acknowledgment that, despite President Trump's grousing about high drug prices earlier this year, they're unlikely to change soon.
[font size=1]-snip-[/font]
Read more: https://www.washingtonpost.com/news/to-your-health/wp/2017/06/08/how-these-cancer-doctors-plan-to-reduce-patients-drug-costs-without-touching-prices/
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
2 replies, 4438 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (3)
ReplyReply to this post
2 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Cancer drug prices are so high that doctors will test cutting doses (Original Post)
Eugene
Jun 2017
OP
RX companies will just do what utility companies do when summer hits and people dont need
Eliot Rosewater
Jun 2017
#1
Eliot Rosewater
(31,113 posts)1. RX companies will just do what utility companies do when summer hits and people dont need
their heaters anymore, make what they do use that much more expensive.
Absurd that we allow for profit anything to be involved in life and death decisions.
PoindexterOglethorpe
(25,873 posts)2. Well isn't that interesting.
Lower dosage, fewer side effects, just as effective. Makes you wonder about the original testing to establish the dosage.